Cell Press Journals: How to Choose

Cell Press publishes some of the most influential journals in biology - from the flagship Cell to specialist titles like Cancer Cell, Immunity, Neuron, and Cell Metabolism, down to the broad-scope Cell Reports. The ecosystem is connected by a powerful transfer system and a shared editorial philosophy that values mechanistic depth and complete stories.

Understanding the hierarchy isn't about prestige rankings. It's about strategic submission. Each journal has a distinct scope, audience, and bar. A paper that's a strong Cancer Cell candidate would be wrong for Immunity. A paper that's too focused for Cell might be perfect for Molecular Cell. And the Cell Press transfer system - including the innovative Multi-Journal Submission option - means that entering the ecosystem at any point gives you access to the whole family.

This guide maps the Cell Press field for biologists making submission decisions. Where does each journal fit? How does the transfer cascade work? And where should your paper actually go?

Head-to-Head Comparison

The Hierarchy: Where Each Journal Sits

Cell sits at the top - it's the flagship, requiring papers that reshape understanding across all of biology. A Cell paper must interest immunologists, neuroscientists, and cancer biologists simultaneously. The bar isn't just great science; it's great science with sweeping implications. Most Cell papers represent 3–5 years of work with 7–10 figures.

Cancer Cell (IF 44.5) actually outranks Cell in raw impact factor. It's the highest-impact dedicated cancer journal, above Nature Cancer and Cancer Discovery. The editorial vision is explicitly "integrated": cancer as a system of tumor cells, microenvironment, microbiota, and host physiology. Patient-centered relevance is expected even for basic work.

Cell Metabolism (IF 30.9) dominates the metabolism space, well above Nature Metabolism (20.8). It wants mechanistic insight into metabolic processes with disease relevance - diabetes, obesity, cancer metabolism, immunometabolism. Descriptive metabolomics without mechanism won't clear the bar.

Immunity (IF 26.3) is the Cell Press immunology specialist. It requires deeper mechanistic dissection than Nature Immunology, which sometimes accepts more observational work. The bar is fundamental new immunological insight at molecular, cellular, or organism level.

Neuron (IF 15.0) demands mechanistic completeness in neuroscience. Where Nature Neuroscience may accept a striking observation, Neuron wants the full story: what happens, how, and why. Multi-technique, multi-level evidence is the norm.

Molecular Cell (IF 16.6) is Cell's molecular biology arm. It values deep biochemical and structural dissection - cryo-EM structures revealing mechanisms, chromatin remodeling at atomic resolution, RNA biology at the molecular level. The scope is narrower but the mechanistic depth expected is extreme.

Cell Reports (IF 6.7) is the accessible tier - but not Cell-lite. It publishes focused, single-point studies that provide clear biological insight. The Report format (4,000 words, 4 figures) is its signature. A clean story with one strong finding is ideal.

The Transfer System: How It Actually Works

The Cell Press transfer system is one of the most valuable features of the ecosystem. When a paper is rejected from one journal, editors can offer to transfer it - with the full manuscript and reviewer comments - to another Cell Press journal. The receiving journal can use those reviews, potentially accepting without additional external review.

In practice, the most common transfer cascades look like this:

Cell → Molecular Cell or discipline-specific journal → Cell Reports → iScience. A paper rejected from Cell for being "too specialized" might be perfect for Cancer Cell, Immunity, or Cell Metabolism. If still too narrow, Cell Reports catches solid biology that doesn't need the full mechanistic marathon. iScience sits at the bottom as a guaranteed-review destination.

Cancer Cell → Cell Reports → Cell Reports Medicine → iScience. Cancer papers that don't clear the Cancer Cell bar for systemic novelty can land at Cell Reports with their review history intact.

Immunity → Cell Reports → iScience. Immunology papers too narrow or too descriptive for Immunity find homes in Cell Reports.

The transfer option typically expires after 90 days. Taking a transfer isn't a consolation prize - it's a strategic shortcut that saves months of re-review. Cell Reports papers that started as Cell submissions are treated exactly the same as direct submissions once published.

Multi-Journal Submission: The Game-Changer

Cell Press introduced Multi-Journal Submission (MJS), allowing authors to submit to up to 30 Cell Press journals simultaneously. A dedicated Community Editor coordinates parallel consideration. Editors from different journals discuss your paper independently and decide which journal is the best fit.

This is genuinely field-changing for authors. Instead of serial submission - submit to Cell, wait 2 weeks for desk rejection, submit to Immunity, wait 2 more weeks - you submit once and the system sorts it out. Cell Press data shows MJS papers reach acceptance ~42 days faster than traditional sequential submissions. Slightly more MJS papers get sent for review (~32.5% vs ~30.6% for direct submissions), suggesting the system helps papers find their right home.

To use MJS effectively: include your top 3–4 target journals when submitting. Be honest in your cover letter about where you think the paper fits. If you think it's a Cell or Cancer Cell paper, say so - but also indicate which specialist journals you'd consider. The system works best when authors and editors share expectations.

One caveat: MJS doesn't guarantee consideration at every journal you list. Editors at each journal still make independent decisions. But it eliminates the months wasted on serial rejections.

Common Editorial Values Across Cell Press

Despite their different scopes, all Cell Press journals share certain editorial expectations:

STAR Methods compliance is non-negotiable. The Structured, Transparent, Accessible Reporting format requires a Key Resources Table, detailed statistical reporting, and data/code availability. Missing these elements delays or blocks submission at every Cell Press journal.

Graphical abstracts matter. Cell Press promotes papers heavily on social media using graphical abstracts. A compelling graphical abstract drives downloads and editorial attention. Invest serious time in it.

In-house professional editors make all decisions. Every Cell Press journal uses full-time PhD editors, not academic editorial boards. This means faster, more consistent decisions - but also means you can't lobby board members. Your paper needs to speak for itself.

Reviewer cross-consultation is standard. Editors enable discussions between reviewers before finalizing decisions. This produces more nuanced, less contradictory feedback than traditional independent reviews.

The 12-month open archive applies to all subscription-track papers: content becomes freely accessible after 12 months regardless of OA choice. Gold OA is optional at $10,400 for most Cell Press journals.